C81.37

Clinical Causes: The exact cause of Hodgkin lymphoma remains unknown, but it is believed to involve genetic, environmental, and viral factors. Certain infections, such as the Epstein-Barr virus, have been associated with an increased risk. Family history of lymphoma or other lymphatic cancers may predispose individuals. Environmental exposures to certain chemicals or toxins could potentially play a role, though evidence is limited.

Key Symptoms: Swelling of lymph nodes in the neck, armpits, or groin Unintended weight loss Persistent fever Night sweats Fatigue or weakness Abdominal pain or swelling, which may be related to spleen enlargement Itching skin without an apparent cause Symptoms related to spleen involvement, such as feeling full after eating small amounts

Diagnosis Path: Diagnosing lymphocyte depleted Hodgkin lymphoma in the spleen involves several steps: - Physical examinations to check for lymph node and spleen swelling - Blood tests to evaluate overall health and look for signs of anemia or infection - Imaging tests such as CT scans, PET scans, or ultrasound to visualize lymphatic tissues and spleen - Biopsy of affected lymph nodes or spleen tissue to confirm the presence of Hodgkin lymphoma and determine its subtype - Additional laboratory tests may be performed to assess the extent of disease spread and organ involvement

Treatment Protocols: The management of lymphocyte depleted Hodgkin lymphoma typically includes: - Chemotherapy, often using regimens tailored to the lymphoma subtype and disease stage - Radiation therapy to target specific lymphatic sites or the spleen - Targeted therapies or immunotherapies, especially in cases resistant to standard treatments - Stem cell transplantation in advanced or relapsed cases Treatment plans are developed based on individual health factors, disease stage, and response to initial therapies. Close monitoring and follow-up are essential to managing side effects and assessing treatment efficacy.